CYP3A5

Revision as of 20:46, 7 January 2009 by Swilliams (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Cytochrome P450, family 3, subfamily A, polypeptide 5
Identifiers
Symbols CYP3A5 ; CP35; P450PCN3; PCN3
External IDs Template:OMIM5 Template:MGI HomoloGene88340
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for CYP3A5

Articles

Most recent articles on CYP3A5

Most cited articles on CYP3A5

Review articles on CYP3A5

Articles on CYP3A5 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CYP3A5

Images of CYP3A5

Photos of CYP3A5

Podcasts & MP3s on CYP3A5

Videos on CYP3A5

Evidence Based Medicine

Cochrane Collaboration on CYP3A5

Bandolier on CYP3A5

TRIP on CYP3A5

Clinical Trials

Ongoing Trials on CYP3A5 at Clinical Trials.gov

Trial results on CYP3A5

Clinical Trials on CYP3A5 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CYP3A5

NICE Guidance on CYP3A5

NHS PRODIGY Guidance

FDA on CYP3A5

CDC on CYP3A5

Books

Books on CYP3A5

News

CYP3A5 in the news

Be alerted to news on CYP3A5

News trends on CYP3A5

Commentary

Blogs on CYP3A5

Definitions

Definitions of CYP3A5

Patient Resources / Community

Patient resources on CYP3A5

Discussion groups on CYP3A5

Patient Handouts on CYP3A5

Directions to Hospitals Treating CYP3A5

Risk calculators and risk factors for CYP3A5

Healthcare Provider Resources

Symptoms of CYP3A5

Causes & Risk Factors for CYP3A5

Diagnostic studies for CYP3A5

Treatment of CYP3A5

Continuing Medical Education (CME)

CME Programs on CYP3A5

International

CYP3A5 en Espanol

CYP3A5 en Francais

Business

CYP3A5 in the Marketplace

Patents on CYP3A5

Experimental / Informatics

List of terms related to CYP3A5

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cytochrome P450, family 3, subfamily A, polypeptide 5, also known as CYP3A5, is a human gene.

This gene,CYP3A5, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. The enzyme metabolizes drugs such as nifedipine and cyclosporine as well as the steroid hormones testosterone, progesterone and androstenedione. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. This cluster includes a pseudogene, CYP3A5P1, which is very similar to CYP3A5. This similarity has caused some difficulty in determining whether cloned sequences represent the gene or the pseudogene.[1]

See also

References

  1. "Entrez Gene: CYP3A5 cytochrome P450, family 3, subfamily A, polypeptide 5".

Further reading

  • Smith G, Stubbins MJ, Harries LW, Wolf CR (1999). "Molecular genetics of the human cytochrome P450 monooxygenase superfamily". Xenobiotica. 28 (12): 1129–65. PMID 9890157.
  • Lee SJ, Goldstein JA (2006). "Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests". Pharmacogenomics. 6 (4): 357–71. doi:10.1517/14622416.6.4.357. PMID 16004554.
  • Aoyama T, Yamano S, Waxman DJ; et al. (1989). "Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine". J. Biol. Chem. 264 (18): 10388–95. PMID 2732228.
  • Schuetz JD, Molowa DT, Guzelian PS (1989). "Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver". Arch. Biochem. Biophys. 274 (2): 355–65. PMID 2802615.
  • Murray GI, Pritchard S, Melvin WT, Burke MD (1995). "Cytochrome P450 CYP3A5 in the human anterior pituitary gland". FEBS Lett. 364 (1): 79–82. PMID 7750548.
  • Jounaïdi Y, Guzelian PS, Maurel P, Vilarem MJ (1995). "Sequence of the 5'-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7". Biochem. Biophys. Res. Commun. 205 (3): 1741–7. doi:10.1006/bbrc.1994.2870. PMID 7811260.
  • McKinnon RA, Burgess WM, Hall PM; et al. (1995). "Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues". Gut. 36 (2): 259–67. PMID 7883227.
  • Kolars JC, Lown KS, Schmiedlin-Ren P; et al. (1995). "CYP3A gene expression in human gut epithelium". Pharmacogenetics. 4 (5): 247–59. PMID 7894497.
  • Lown KS, Kolars JC, Thummel KE; et al. (1995). "Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test". Drug Metab. Dispos. 22 (6): 947–55. PMID 7895614.
  • Schuetz JD, Beach DL, Guzelian PS (1994). "Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver". Pharmacogenetics. 4 (1): 11–20. PMID 8004129.
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
  • Schuetz JD, Schuetz EG, Thottassery JV; et al. (1996). "Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells". Mol. Pharmacol. 49 (1): 63–72. PMID 8569713.
  • Jounaïdi Y, Hyrailles V, Gervot L, Maurel P (1996). "Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein?". Biochem. Biophys. Res. Commun. 221 (2): 466–70. PMID 8619878.
  • Hakkola J, Pasanen M, Hukkanen J; et al. (1996). "Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta". Biochem. Pharmacol. 51 (4): 403–11. PMID 8619884.
  • Hakkola J, Raunio H, Purkunen R; et al. (1996). "Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy". Biochem. Pharmacol. 52 (2): 379–83. PMID 8694864.
  • Huang Z, Fasco MJ, Figge HL; et al. (1997). "Expression of cytochromes P450 in human breast tissue and tumors". Drug Metab. Dispos. 24 (8): 899–905. PMID 8869826.
  • Kivistö KT, Bookjans G, Fromm MF; et al. (1997). "Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue". British journal of clinical pharmacology. 42 (3): 387–9. PMID 8877031.
  • Janardan SK, Lown KS, Schmiedlin-Ren P; et al. (1997). "Selective expression of CYP3A5 and not CYP3A4 in human blood". Pharmacogenetics. 6 (5): 379–85. PMID 8946469.
  • Anttila S, Hukkanen J, Hakkola J; et al. (1997). "Expression and localization of CYP3A4 and CYP3A5 in human lung". Am. J. Respir. Cell Mol. Biol. 16 (3): 242–9. PMID 9070608.
  • Hukkanen J, Hakkola J, Anttila S; et al. (1997). "Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes". Mol. Carcinog. 20 (2): 224–30. PMID 9364212.

Template:SIB

Template:WH Template:WikiDoc Sources